IXC invex therapeutics ltd
Add to My Watchlist 7.78% ! 9.7¢

News: IXC Invex Therapeutics Announces Granting Of Orphan Drug Designation For Exenatide

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    23/06/23
    10:40
    Post #: 68433382

    June 23 (Reuters) - Invex Therapeutics Ltd (IXC) :

    • GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN INJURY
    • GRANTING OF ORPHAN DRUG DESIGNATION FROM EUROPEAN MEDICINES AGENCY
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
NEWS Access the latest ASX news here
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.7¢ 		Change
0.007(7.78%) 		Mkt cap ! $7.289M
Open High Low Value Volume
9.6¢ 9.7¢ 9.6¢ $2.444K 25.41K

Buyers (Bids)

No. Vol. Price($)
1 42086 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 8999 1
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.